Litigation Details for Eagle Pharmaceuticals, Inc. v. Accord Healthcare Inc. (D. Del. 2022)

Eagle Pharmaceuticals, Inc. v. Accord Healthcare Inc. (D. Del. 2022)

Docket		Date Filed	2022-05-27
Court	District Court, D. Delaware	Date Terminated	2022-11-20
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	None	Referred To
Patents	10,010,533; 8,609,707; 9,265,831; 9,572,796; 9,572,797
Link to Docket	External link to docket

Details for Eagle Pharmaceuticals, Inc. v. Accord Healthcare Inc. (D. Del. 2022)

Date Filed	Document No.	Description	Snippet	Link To Document
2022-07-06	10	Complaint - Amended	related patents, U.S. Patent Nos. 9,265,831 (the “’831 patent”) and 9,572,797 (the “’797 patent”), as …expiration of Eagle’s U.S. Patent No. 11,103,483 (“the ’483 patent,” or “the Patent-in-Suit”). … 1. This is an action for patent infringement under the patent laws of the United States, Title…the owner and assignee of the ’483 patent. The ’483 patent is listed in connection with BELRAPZO… the Patent-in-Suit. 34. BELRAPZO® is an embodiment of the claims of the Patent-in-Suit	External link to document
2022-05-27	3	Patent/Trademark Report to Commissioner of Patents	,265,831 ;9,572,796 ;9,572,797 ;10,010,533 ;11,103,483. (mpb) (Entered: 05/31/2022) 27 May 2022 … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,609,707 ;9,265,831… 21 November 2022 1:22-cv-00704 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-11-20	31	Patent/Trademark Report to Commissioner of Patents	,265,831 ;9,572,796 ;9,572,797 ;10,010,533 ;11,103,483. (Attachments: # 1 Final Judgment of Non-Infringement… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,609,707 ;9,265,831… 21 November 2022 1:22-cv-00704 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document